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INTRODUCTION
Sacral tumors are relatively uncommon. The majority of sacral 
tumors are metastatic tumors, although primary sacral tumors, 
such as primary bone tumors, neurogenic or congenital tu-
mors, arising from the sacrum do occur.1-3 During diagnosis, 
sacral tumors are often missed at an early stage because of 
their indefinite clinical and unclear radiological characteris-
tics. Due to their characteristics and growth patterns, these lo-
cally aggressive tumors often have huge masses and lead to 
complications.4 Computed tomographic (CT) scanning and 
magnetic resonance imaging (MRI) can aid in diagnosis in 
terms of the location, size, characteristics of these tumors, as 
well as in preoperative planning.
Most sacral tumors, except for metastatic tumors, are resis-
tant to radiotherapy (RTx) and chemotherapy (CTx). There-
fore, wide excision is typically the treatment of choice, and sev-
eral surgical approaches and techniques have been described. 
Depending on the size and extent of the tumors, a single-stage 
posterior or a combined antero-posterior approach can be 
used. 
The aim of this study was to review the management of sacral 
tumors, including symptoms, tumor features, perioperative 
management, surgical treatments, and complications.
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Purpose: This study aimed to present our experiences with a precise surgical strategy for sacrectomy.
Materials and Methods: This study comprised a retrospective review of 16 patients (6 males and 10 females) who underwent sa-
crectomy from 2011 to 2019. The average age was 42.4 years old, and the mean follow-up period was 40.8 months. Clinical data, 
including age, sex, history, pathology, radiographs, surgical approaches, onset of recurrence, and prognosis, were analyzed.
Results: The main preoperative symptom was non-specific local pain. Nine patients (56%) complained of bladder and bowel 
symptoms. All patients required spinopelvic reconstruction after sacrectomy. Three patients, one high, one middle, and one hemi-
sacrectomy, underwent spinopelvic reconstruction. The pathology findings of tumors varied (chordoma, n=7; nerve sheath tu-
mor, n=4; giant cell tumor, n=3, etc.). Adjuvant radiotherapy was performed for 5 patients, chemotherapy for three, and combined 
chemoradiotherapy for another three. Six patients (38%) reported postoperative motor weakness, and newly postoperative blad-
der and bowel symptoms occurred in 5 patients. Three patients (12%) experienced recurrence and expired.
Conclusion: In surgical resection of sacral tumors, the surgical approach depends on the size, location, extension, and pathology 
of the tumors. The recommended treatment option for sacral tumors is to remove as much of the tumor as possible. The level of 
root sacrifice is a predicting factor for postoperative neurologic functional impairment and the potential for morbidity. Pre-oper-
ative angiography and embolization are recommended to prevent excessive bleeding during surgery. Spinopelvic reconstruction 
must be considered following a total or high sacrectomy or sacroiliac joint removal.
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MATERIALS AND METHODS
We retrospectively reviewed the records of 77 patients with 
sacral tumors who were treated between October 2011 and 
September 2019. Patients who underwent only tumor remov-
al or surgical biopsy, as well as those with an intradural tumor, 
dermal or epidermal lesions, or recurrence after a previous 
surgery at other hospitals, were excluded. A total of 16 patients 
(6 males and 10 females) were analyzed. The mean age was 
42.4 years (range, 16–79 years), and the mean follow-up period 
was 40.8 months (range, 12–79 months).
All of the patients underwent radiographs of the lumbosa-
cral spine, including both sacroiliac (SI) joints, as well as CT 
scans and MRIs. The tumors were then classified by growth 
patterns according to guidelines for sacral tumors proposed 
by Wei, et al.3 (Table 1).
The clinical data of the patients, including age, sex, history, 
pathology, radiographs, treatment, recurrence, and prognosis, 
were analyzed. We obtained approval for this study from our 
Institutional Review Board (number: 3-2019-0128).
Surgical procedures
The surgical approaches differed between cases depending 
on the pathology, location, and extent of the tumor. 
There is a notable difference between the upper and lower 
sacrum regarding spinopelvic continuity.4 Additionally, pre-
sacral tumor protrusion of the tumor into the pelvic cavity and 
involvement of the SI joint and vessels surrounding and feed-
ing the tumor are key factors in determining the surgical ap-
proach, specifically between a single posterior or a combined 
antero-posterior approach.
After deciding on the surgical approach, sacrectomy was 
considered. According to the system of Fourney, et al.,1 the sa-
crum is divided into three regions of the upper, middle, and 
lower sacrum by S1–S2 and S2–S3 junctions. Based on the tu-
mor extension, en bloc resection of primary sacral tumors was 
classified into five types (Table 2).1,5,6 
Combined antero-posterior approach
A combined antero-posterior approach is appropriate for type I 
tumors with presacral masses or type II tumors complicated 
by anterior masses greater than 5 cm. In type I, an en bloc re-
section with an anterior lumbosacral discectomy is useful. In 
lateral tumor invasion with involvement of the SI joint, en bloc 
resection and anterior SI joint removal are appropriate. Addi-
tionally, if the peritumoral surrounding vessels are complicat-
ed, an anterior approach is helpful for vessel ligation.
Surgery was performed in two stages. The tumor was ap-
proached anteriorly through an anterior midline transperito-
neal or retroperitoneal approach.7 Recently, an anterior ap-
proach using laparoscope and retroperitoneoscope has been 
introduced.8,9 In most cases, it was difficult to accurately iden-
tify masses in the anterior; therefore, the tumor margin was ex-
plored and surgical vessel ligation was performed. Lateral dis-
section of the sacral ala allowed for identification of the lumbar 
trunk (L4–5) of the lumbosacral plexus. The SI joint was then 
identified lateral to these nerve roots, and bilateral partial ven-
tral SI osteotomy was performed. The lumbosacral disc was 
exposed and removed along with the anterior aspect of the an-
nulus fibrosis. 
In stage II, via a posterior incision extending from L2 to be-
yond the coccyx, the posterior iliac crests, greater sciatic fo-
ramina, and sciatic nerves were exposed bilaterally, as well as 
the L3–5 spinous processes, facet joints, and transverse pro-
cesses. An L5 laminectomy exposed the dural sac and cauda 
equine below this level. The sacral nerve roots were then di-
vided, and the dural sac was amputated according to one of 
two methods: 1) amputation before closure, after which the 
dural sac was closed with a double layer of sutures, or 2) the 
dural sac was tied up several times first, after which the am-
putation was performed (Fig. 1). The remaining posterior L5–
S1 intervertebral disc was then excised, and the posterosupe-
rior iliac spines were removed, facilitating cutting the bilateral 
osteotomes lateral to the ala of the sacrum and parallel to the 
SI joints, thus completing the osteotomy cuts made in these 
planes during stage I. Partial mobilization of the sacrum facili-
tated identification of the sacrospinous and sacrotuberous lig-
aments, which were then transected. The sacral nerve roots 
were divided as they exited the sacrum, protecting the sciatic 
nerves from injury. The entire sacrum along with the neoplasm 
was then removed en bloc.1,10-12 
Single posterior approach
A single posterior approach is suitable for type II or III tumors 
with tumor extension to the anterior of less than 5 cm.




Confined to the sacral canal along with enlargement of the sacral 
  canal
Type II
Forward out of sacral neural foramens, with formation of a huge 
  presacral lump
Type III
Spreads both anteriorly and posteriorly with formation of lumps 
  anterior and posterior to the sacrum
Type IV
Confined to the presacral space, with no tumor present 
  in the sacral canal
Table 2. En bloc Resection of Primary Sacral Tumors
Classification
Type I Upper only, upper and middle, or upper to lower
Type II Middle and lower
Type III Only lower
Type IV Eccentric lesions
Type V Fifth lumbar vertebra is involved and has to be resected
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Reconstruction
In patients who underwent total sacrectomy, spinopelvic re-
construction was performed to facilitate early mobilization and 
better ambulation because of the spinopelvic discontinuity 
and instability.13,14 Fixation methods included various combi-
nations of spinopelvic fixation (SPF), iliac screw fixation (ISF), 
and pelvic ring reconstruction (PR). 
Two vertical L-shaped rods were positioned bilaterally in a 
manner allowing fixation to the L3–5 pedicles on each side ac-
cording to the Galveston technique.15 Two to three cross-con-
necting rods were used to secure the vertical rods to each oth-
er. Distally, the vertical rods were directed laterally into the 
ilium between the two cortices. Both autologous and allogen-
ic bone grafts were placed to promote fusion of the transverse 
processes and lamina from L4 distally to the medioposterior 
aspect of the transected ilium bilaterally. An allograft strut was 
used to close the space between the two ilia, and a bone fusion 
promoter and bone chips were added across the graft area to 
facilitate fusion of the entire defect. In cases where the dead 
space was wide, a gluteus muscle and skin flap were then uti-
lized. In ordinary cases, a conventional muscle and skin clo-
sure was performed after placement of closed drains.16-18
Recently, 3D-printed implant reconstruction (3DIR) has been 
attempted. Therein, customized implants, which are fitted to a 




The chief complaint of the patients was non-specific local pain. 
In terms of pre-operative motor deficits, 3 patients (19%) had 
leg weakness. Nine patients (57%) complained of bladder and 
bowel symptoms, such as voiding difficulty, urinary frequency 
or urgency, constipation, and residual sense after urination or 
defecation (Table 3).








  1 F/70 LP 12 Intact UF, CoP, DAT 9.8×3.5×7.5 II Middle Thyroid Ca. Chordoma -/- -
  2 F/23 LBP   6 Intact UF, CoP 8.5×8.0×9.8 II Upper Pul. Tbc, NF MPNST +/+ -
  3 F/39 LP   6 Intact Intact 14.0×9.5×16.1 III Upper Appendicitis Osteosarcoma +/- -
  4 F/38 ButP   1 Both leg IV Intact 10.7×10.3×11.0 III Upper - Chordoma +/- -
  5 F/41 ButP 18 Intact VD 3.5×2.5×2.5 II Lower - Chordoma -/- -
  6 M/29 CP 24 Intact Intact 4.5×3.7×2.7 II Lower - - -/- +
  7 F/58 ButP 12 Intact VD, CoP 8.5×6.5×9.0 III Upper - - -/- -
  8 F/58 LBP 24 Intact Intact 3.0×6.4×5.1 III Middle - Schwannoma -/- -
  9 M/27 CP   4 Intact VD, CoP 8.5×4.5×4.3 II Middle - GCT +/+ +
10 M/60 CP   3 Intact VD, CoP, DAT 5.7×6.4×9.0 III Middle HTN Chordoma +/+ -
11 F/79 LBP   4 Intact VD, CoP, DAT 5.8×4.5×6.3 II Lower HTN Chordoma -/- -
12 F/16 LBP   4 Intact Intact 3.9×2.9×3.9 I Upper - Osteosarcoma +/+ -
13 M/55 LBP 36 Intact Intact 4.5×4.8×5.3 III Middle - Chordoma -/- -
14 F/32 LP   7 Intact Intact 6.0×3.2×5.2 I Upper - GCT -/- -
15 M/21 LP   4 Right leg III VD, CoP 8.8×9.0×9.0 II Middle - GCT +/+ +
16 M/32 LP 12 Left leg III VD, CoP 4.6×8.5×5.7 II Lower - - +/+ -
A/E, angiography/embolization; B/B, bladder/bowel; ButP, buttock pain; Ca., cancer; CC; chief complaint; CoP, constipation; CP; coccyx pain; CT, computed tomogra-
phy; D, duration; DAT, decreased anal tone; DM, diabetes mellitus; F, female; G, growth pattern; GCT, giant cell tumor; HTN, hypertension; LBP, low back pain; LP, 
leg pain; M, male; Mo, months; MPNST, malignant peripheral nerve sheath tumor; NF, neurofibroma; Pul. Tbc, pulmonary tuberculosis; SB, sperm bank; UF, urinary 
frequency; VD, voiding difficulty.
Fig. 1. (A) Dural sac was lifted using a clamp. After that, the dural sac was 
closed with a double layer of sutures after amputation. (B) Dural sac was 
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Pre-operative management
Before surgery, 13 patients underwent CT-guided biopsy for 
surgical and adjuvant therapy planning. 
Among possible complications, excessive blood loss is the 
most fatal and dangerous. Preoperative angiography was per-
formed to identify highly vascular tumors. Subsequently, the 
decision between angiographic embolization or an anteriorly 
approached surgical ligation, or both, was made. In this study, 
8 patients underwent preoperative angiography. For six of 
those patients, angiographic embolization was then performed 
using polyvinyl alcohol (150–250 µm or 250–300 µm) or coils via 
multiple feeding arteries from the internal iliac artery (Fig. 2). 
Among six male patients, three were adults in their 20s who 
deposited their sperm in a sperm bank due to the risk of sexu-
al dysfunction. The other patient in his 30s tried to deposit his 
sperm in a sperm bank, but was unable to do so, because ejac-
ulation was impossible due to pain and it was thought that 
there would be no problems with sexual function after surgery.
Surgical management
Twelve patients underwent a single-stage posterior approach, 
and 3 patients underwent a two-stage antero-posterior ap-
proach. One patient underwent a two-stage anterolateral ap-
proach due to a chondrosarcoma located in an eccentric hemi-
sacrum. The average blood loss was 5381 mL, and the average 
operation time was 8.24 hours.
In total, 5 patients underwent surgical iliac vessel ligation, 
all of which were performed after angiography to confirm a 
highly vascular tumor. In three cases, pre-operative emboliza-
tion was performed first, but was not successful. 
All patients who underwent a total sacrectomy and one pa-
tient who underwent a hemi-sacrectomy required SPF be-
cause the tumor extended S1 superiorly and the SI joint later-
ally. Because SI joint removal was required when the tumor 
was removed, they also required ISF and PR. A total of 2 pa-
tients underwent 3DIR with SPF and ISF, according to the meth-
od of Kim, et al.19
Two patients, one each with a high or middle sacrectomy, 
also underwent SPF. The patients’ tumors were large and ex-
tended to S1 but did not involve the root. Therefore, the upper 
part was removed only, and high or middle sacrectomy was 
done. In addition, because the SI joint was also involved, ISF 
was done in addition to SPF. For the patient who received a 
high sacrectomy, PR was also performed to prevent complica-
tions stemming from a pelvic gap after tumor removal. The 
procedure was performed by orthopedic surgeons using a uni-
versal locking system plate (Zimmer Biomet, Warsaw, IN, USA) 
and fresh-frozen femoral head allograft struts (Fig. 3).
A vertical skin incision was performed on most patients who 
underwent a posterior-only approach. However, for 5 patients 
with a large tumor extending up to S1 or laterally to the SI joint, 
a total or high sacrectomy was performed using an inverted T- 
or Y-shaped skin incision. The inverted Y incision allowed for 
easier tumor removal due to a wider operation field, compared 
to the inverted T incision, although the ensuing large void and 
severe skin defect required a muscle flap using the gluteus 
maximus to be created by plastic surgeons (Table 4).
Postoperative management
Seven patients (44%) complained of sensory changes, such as 
tingling sensation, numbness, and hypoesthesia. Six patients 
(38%) complained of post-operative motor deficits. Fourteen 
patients (88%) complained of bladder and bowel symptoms. 
Of the patients with chordoma, five received adjuvant RTx. 
Fig. 2. (A) Angiography for highly vascular tumors. There were multiple feeding arteries from the internal iliac artery (white arrow). (B) Angiographic em-
bolization was performed using polyvinyl alcohol via a feeding artery from the internal iliac artery (white dotted circle). After angiographic embolization, 
there was no vascular flow from feeding arteries.
A B
63
Kwang-Ryeol Kim, et al.
https://doi.org/10.3349/ymj.2021.62.1.59
The patients with chondrosarcoma and osteosarcoma and one 
with giant cell tumor (GCT) received adjuvant RTx and CTx. 
One patient with neurofibroma received adjuvant CTx due to 
lung metastasis, not the sacral tumor. An additional patient 
with GCT received neoadjuvant CTx to decrease their tumor 
size. Another patient with Ewing’s sarcoma received palliative 
CTx. Three patients (19%) experienced post-operative recur-
rence (37 and 45 months for chordoma and 13 months for 
chondrosarcoma), and all of those patients expired (Table 5). 
DISCUSSION
Sacral tumors are account for approximately 1–7% of all spinal 
tumors.20 Chordoma is the most common among the primary 
malignant bone tumors, and GCT is one of the most frequent-
ly seen benign lesions arising from the sacrum. Although GCT 
is a benign tumor, it is very vulnerable to local recurrence.21,22 
Neurogenic tumors can also occur in the sacrum. Sacral neu-
rogenic tumors, which comprise schwannoma and neurofi-
Fig. 3. (A) Intraoperative field view of spinopelvic reconstruction. (B) Postoperative radiographs of spinopelvic reconstruction (anteroposterior and lateral 
views). (C) Illustration of spinopelvic reconstruction. Spinopelvic fixation (L2 to L5) and iliac screw fixation were performed. Pelvic ring reconstruction was 
done using a universal locking system plate and fresh-frozen femoral head allograft strut.
A B C







IVL SIJR GMF Instrumentation OPT (HR) BL (mL)
  1 Post. Inverted T Total S1 - - + L2-S1, ISF, PR 10.77 1900
  2 Ant.-Post. Midline High S2 + + + L2-5, ISF, PR 10.97 4700
Inverted Y
  3 Ant.-Lat. Midline Hemi - + - - - 13.02 2370
Vertical
  4 Ant.-Post. Midline Total S1 + + + L2-5, ISF, PR 14.83 22100
Inverted Y
  5 Post. Vertical Middle S3 - - - - 5.47 650
  6 Post. Vertical Low S4 - - - - 2.05 230
  7 Post. Vertical Middle S3 - + - L3-S1, ISF 11.83 11100
  8 Post. Vertical Low S4 - - - - 3.60 2200
  9 Post. Vertical Middle S3 + - - - 8.72 8000
10 Post. Inverted Y High S2 - - + - 5.93 3650
11 Post. Vertical Middle S3 - - - - 6.80 2000
12 Ant.-Post. Midline Hemi S1 + + + L3-S1, ISF, 3DIR 6.72 4500
Inverted Y
13 Post. Inverted Y High S2 - - + - 6.28 2600
14 Post. Inverted Y Total S1 - + + L3-S1, ISF, 3DIR 8.95 8000
15 Post. Vertical High S2 - - - - 11.87 10300
16 Post. Vertical Middle S3 - - - - 4.07 1800
3DIR, 3 dimensional-printed implant reconstruction; Ant., anterior; BL, blood loss; GMF, gluteus muscle flap; HR, hours; IVL, iliac vessel ligation; ISF, iliac screw fixa-
tion; OPT, operation times; PR, pelvic ring reconstruction; SIJR, sacroiliac joint removal; TR, tumor removal.
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bromas, arise from the sacral nerve, grow along the bony neu-
ral foramen, and extend inside the sacral canal.4,23 In our study, 
chordoma was the most prevalent, followed by nerve sheath 
tumors.
En bloc resection is associated with decreased local recur-
rence and increased survival rates compared to intralesional 
resection. However, injury to the sacral nerve roots may occur 
intra-operatively, leading to post-operative neurological dys-
function.1,3,5,6,10 To do sacrectomy, dural sac amputation must 
be performed. In order to prevent postoperative cerebrospinal 
fluid leakage, careful watertight ties with non-absorbable silk 
suture material are required.24 As mentioned above, angiogra-
phy is needed to identify highly vascular tumors. Pre-operative 
embolization can reduce intra-operative blood loss and time, 
increase tumor resectability, and improve visualization of the 
operative field. Even partial embolization may reduce intra-
operative bleeding.25,26 In addition, patients who may wish to 
procreate in the future should be advised that sexual dysfunc-
tion may occur after surgery, allowing them to store their sperm 
in advance of the procedure. 
Identifying tumor characteristics in advance through pre-
operative CT-guided biopsy can also determine the surgical 
methods used and the appropriate treatment after surgery. 
However, during sacrectomy in a chordoma patient and biop-
sy in a resected tumor removed for intraoperative frozen, high-
pressure exudate was observed coming from inside the tumor 
(Fig. 4). If a pre-operative CT-guided biopsy had been per-
formed, we could not have ruled out the possibility that tu-
mor cells had come out along the wound tract and invaded the 
surrounding area. Therefore, we have to ensure extensive tu-
mor removal including the biopsy tract and skin. In addition 
to this method, if small chordoma is suspected based on pre-
operative MRI, a total tumor removal without pre-operative 
biopsy is recommended to avoid tumor seeding.
The surgical methods to be used are determined in accor-
dance with the size, location, and extension of the tumor. De-
Fig. 4. (A) On magnetic resonance imaging, a 4×4 cm round mass (white dotted circle) was located at S5. (B) Low sacrectomy and en bloc tumor resec-
tion were performed. (C) After en bloc resection, specimens were retrieved for intraoperative frozen biopsy. After biopsy, high-pressure exudate (white 
dotted circle) was observed coming from inside the tumor.
A B C
Table 5. Prognoses after Surgery for Patients with Sacral Tumor
Case Pathology Pain & sensory Motor B/B RTx (T) CTx (R) F/U (mo) Recurrence (mo)
  1 Chordoma ButP, HE(L5) Intact Foley, CoP, DAT 29 - 60 37, Expire
  2 Neurofibroma LP, LT Intact SV (Res), CoP - IE* 79 DF
  3 Chondrosarcoma LBP, LN Lt. ankle I Foley, CoP, DAT 30 Cisplatin 41 13, Expire
  4 Chordoma HE(L5) Both leg III CIC, CoP, DAT - - 53 DF
  5 Chordoma ButP Intact CIC, FI - - 33 DF
  6 Chordoma Intact Intact Intact 37 - 23 DF
  7 Schwannoma Intact Intact UI, CoP - - 18 DF
  8 Schwannoma Intact Intact UI, CoP - - 17 DF
  9 GCT Intact Intact Intact - - 22 DF
10 Chordoma CP Intact CIC, CoP 30 - 67 DF
11 Chordoma ButP Intact UI, CoP 10 - 55 45, Expire
12 Osteosarcoma LBP, LN Lt. leg III VD, CoP 28 MAP 57 DF
13 Chordoma LBP Intact VD, CoP 20 52 DF
14 GCT LBP, ButP Rt. ankle III VD, CoP, DAT - Denosumab 45 DF
15 GCT LBP, LT Both ankle I Foley, CoP, DAT 30 Denosumab 18 DF
16 Ewing’s sarcoma LBP, HE (L3) Lt. leg III Foley, CoP - VIDE 12 OT
B/B, bladder/bowel; ButP, buttock pain; CIC, clean intermittent catheterization; CoP, constipation; CP, coccyx pain; CTx, chemotherapy; DAT; decreased anal tone; 
DF; disease free; FI; fecal incontinence; F/U, follow-up; GCT, giant cell tumor; HE, hypoesthesia; IE, ifosfamide-epirubicin; LBP, low back pain; LN, leg numbness; 
LP, leg pain; Lt., left; LT, leg tingling; MAP, methotrexate-doxorubicin-cisplatin; Mo, months; OT, on treatment; R, regimens; Res, residual; Rt., right; RTx, radiothera-
py; SV, self-voiding; T, times; UI, urinary incontinence; VD, voiding-difficulty; VIDE, vincristine-ifosfamide-doxorubicin-etoposide.
*Chemotherapy for lung metastasis.
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cisions are based on the level of sacrifice of the sacral root, 
which can have a direct effect on motor deficits, bladder and 
bowel symptoms, and sexual dysfunction that can occur after 
surgery.1,4,5,10,11,17 Therefore, it is optimal to save the root if pos-
sible. In this study, a single-stage posterior approach was used 
for a GCT patient with a large, hypervascular tumor covering 
the lower part of the S1 body and around the S2 root. During 
the stripping process to save the root, an uncontrolled iliac ves-
sel injury occurred, causing the patient to undergo vessel liga-
tion, resulting in increased operation time and bleeding. If a 
combined antero-posterior approach been planned for the 
surgery, the patient would likely have had a better result: the 
patient has had three surgeries, fortunately leading to a very 
good outcome overall. Indeed, Lee, et al.27 reported, in a case of 
presacral giant schwannoma, that an anterior approach could 
achieve total resection of presacral tumor without sacrificing 
sacral bone and sacral nerve root.
For tumors extending laterally to the SI joint, SI joint remov-
al must be included when the tumor is removed. Six patients 
(38%) underwent SPF due to spinopelvic discontinuity and in-
stability. SPF was performed in the 3 patients who underwent 
a total sacrectomy, followed by ISF and PR. An additional 3 pa-
tients underwent SPF and ISF, two of whom also received 3DIR. 
In cases with a large tumor, long incision, and notable mus-
cle dissection, the resulting void may be large after tumor re-
moval, which can lead to wound dehiscence or necrosis. In our 
study, an inverted T or Y-shaped skin incision was performed 
in 7 patients. A gluteus muscle and/or skin flap was also uti-
lized in these patients to prevent wound problems. 
Adjuvant CTx or RTx should be considered as post-operative 
treatments according to the tumor pathology. In this study, pa-
tient prognosis was primarily affected by pathology and age. 
Three patients expired after recurrence. For the chondrosarco-
ma patient, the sacral lesion was well removed, but the tumor 
had heavily invaded the abdominal cavity such that only a near-
total removal was possible. The remnant tumor was then sub-
jected to adjuvant CTx and RTx, but the patient did not survive. 
Five of the 7 chordoma patients were under 60 years old, and 
the two others were over 70 years old. Unfortunately, despite 
the total sacrectomy and adjuvant CTx and RTx, both of the 
older patients experienced recurrence and expired.
The recommended treatment for sacral tumors is to remove 
as much of the tumor as possible. Surgeons should be careful 
of excessive bleeding during tumor removal, and therefore, pre-
operative angiography and embolization are recommended. 
In addition, the type of sacrectomy should be determined ac-
cording to the location and extension of the tumor, and to re-
duce post-operative complications, all possible efforts should 
be made to save up to the S2 root. In a systematic review paper, 
Zoccali, et al.28 reported that patients who underwent a sacrec-
tomy maintained functionally normal ambulation in 56.2% of 
cases when both S2 roots were spared, in 94.1% when both S3 
roots were spared, and in 100% with more distal resections. 
Normal bladder and bowel function were not present when 
both S2 were cut. When one S2 root was spared, normal blad-
der function was present in 25% of cases; in 39.9% when both 
S2 roots were spared, in 72.7% when one S3 root was spared, 
and in 83.3% when both S3 roots were spared. Abnormal bowel 
function was present in 12.5% of cases when both S1 roots and 
one S2 root were spared, in 50.0% of cases when both S2 roots 
were spared, and in 70% of cases when one S3 root was spared. 
If both S3 roots were spared, bowel function was normal in 94% 
Treatment algorithm for sacral tumors
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Fig. 5. Treatment algorithm for sacral tumors (preoperative and operative management).
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of cases. When even one S4 root was spared, normal bladder 
and bowel function were present in 100% of cases. Unilateral 
sacral nerve root resection preserved normal bladder function 
in 75% of cases and normal bowel function in 82.6% of cases. 
Motor function depended on S1 root involvement. In our study, 
Patients 14 and 15 had tumor invasion around the sacral root, 
and the pathology was GCT. Thus, if en-bloc resection was not 
performed, they were judged to be at high risk of recurrence, 
and the tumors were removed accordingly.
A limitation of our study was the relatively small number of 
sacrectomy cases. This number alone may not be enough to 
establish an optimal surgical strategy. In addition, there were 
differences in the treatment and follow-up periods depending 
on disease entities. Also, with the presence of several different 
operators for each individual, the resulting surgical strategy 
was not unified either. However, we believe that our data will 
contribute to and help in establishing theories as more data 
are added by other researchers.
If a tumor is large, a combined antero-posterior approach is 
recommended over a single-step approach. Spinopelvic re-
construction must be considered following a total or high sa-
crectomy or SI joint removal, and for cases with a large incision 
or void following tumor removal, a muscle and/or skin flap 
should be considered. We have summarized our treatment al-
gorithm in Fig. 5.
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